AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 Earnings Call Transcript

AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 Earnings Call Transcript February 24, 2026

AxoGen, Inc. misses on earnings expectations. Reported EPS is $-0.28034 EPS, expectations were $0.08.

Operator: Good morning, everyone. Joining me on today’s call is Michael Dale, Axogen’s Chief Executive Officer and Director; and Lindsey Hartley, Chief Financial Officer. Michael will discuss fourth quarter and full year 2025 financial results and corporate highlights. Lindsey will then provide details on financial...